LivaNova (LIVN) Gross Margin Growth (3y) (2019 - 2026)
LivaNova (LIVN) Gross Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | -324.00 |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 56.00 |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -164.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 311.00 |
| 10 | LivaNova | 4.35 Bn | 3.81 Bn | 243.75 Mn | 120.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.00 |
| Dec 31, 2025 | -33.00 |
| Sep 30, 2025 | 78.00 |
| Jun 30, 2025 | -474.00 |
| Mar 31, 2025 | -188.00 |
| Dec 31, 2024 | -806.00 |
| Sep 30, 2024 | 287.00 |
| Jun 30, 2024 | 231.00 |
| Mar 31, 2024 | 291.00 |
| Dec 31, 2023 | -557.00 |
| Sep 30, 2023 | 906.00 |
| Jun 30, 2023 | 672.00 |
| Mar 31, 2023 | -211.00 |
| Dec 31, 2022 | 677.00 |
| Sep 30, 2022 | -27.00 |
| Jun 30, 2022 | -43.00 |
| Mar 31, 2022 | 373.00 |
| Dec 31, 2021 | 511.00 |
| Sep 30, 2021 | 253.00 |
| Jun 30, 2021 | -233.00 |